Psychiatry & Neurology Doctors in Yucca Valley, CA Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Dr. Esmaeil Sebti, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 56970 Yucca Trl, Ste 104, Yucca Valley, CA 92284 Phone: 760-365-3711    Fax: 888-523-0327

Dr. Paris Sandra Humphries, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 58383 29 Palms Hwy Ste 101, Yucca Valley, CA 92284 Phone: 760-365-9305

Dr. Duane Kinne Tevis, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 55475 Santa Fe Trl, Yucca Valley, CA 92284 Phone: 760-365-3022    Fax: 760-365-3513

Craig Aaron Kaiser, D. O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 57407 Twentynine Palms Hwy Suite B, Yucca Valley, CA 92284 Phone: 760-366-1541

Homer Leroy Ramsey, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 57407 29 Palms Hwy Ste F, Yucca Valley, CA 92284 Phone: 760-366-1541    Fax: 760-228-1614

News Archive

WHO calls for greater vigilance on correct use of antibiotics against gonorrhoea

Millions of people with gonorrhoea may be at risk of running out of treatment options unless urgent action is taken, according to WHO. Already several countries, including Australia, France, Japan, Norway, Sweden and the United Kingdom are reporting cases of resistance to cephalosporin antibiotics - the last treatment option against gonorrhoea. Every year an estimated 106 million people are infected with gonorrhea, which is transmitted sexually.

Researchers create experimental vaccine for Alzheimer's disease

Researchers at UT Southwestern Medical Center have created an experimental vaccine against beta-amyloid, the small protein that forms plaques in the brain and is believed to contribute to the development of Alzheimer's disease.

Nanopatch Jet Coating drug delivery platform wins 2015 Good Design Award

Invetech, a leader in instrument development, custom automation, and contract manufacturing, and Vaxxas, a biotechnology start-up and developer of the Nanopatch™ needle-free drug delivery technology, have been named winners of the 2015 Good Design Award for development of the Nanopatch Jet Coating Instrument, an advanced technology platform to support needle-free dermal drug delivery research and product development. The award was announced last evening at the Good Design Awards Gala Night held in Sydney, Australia.

Targeted antibiotics provide safe, long-lasting improvement for IBS patients, says study

A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug.

Read more Medical News

› Verified 4 days ago